Meitav Investment House’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-204,490
| Closed | -$6.61M | – | 351 |
|
|
2023
Q3 | $6.61M | Sell |
204,490
-100,837
| -33% | -$3.26M | 0.11% | 111 |
|
|
2023
Q2 | $11M | Buy |
305,327
+274,109
| +878% | +$9.88M | 0.18% | 97 |
|
|
2023
Q1 | $1.25M | Sell |
31,218
-21,786
| -41% | -$870K | 0.02% | 210 |
|
|
2022
Q4 | $2.71M | Sell |
53,004
-14,429
| -21% | -$738K | 0.05% | 169 |
|
|
2022
Q3 | $2.97M | Hold |
67,433
| – | – | 0.05% | 169 |
|
|
2022
Q2 | $3.52M | Sell |
67,433
-1,239
| -2% | -$64.6K | 0.06% | 158 |
|
|
2022
Q1 | $3.56M | Sell |
68,672
-43,858
| -39% | -$2.27M | 0.05% | 179 |
|
|
2021
Q4 | $6.57M | Buy |
112,530
+22,922
| +26% | +$1.34M | 0.11% | 144 |
|
|
2021
Q3 | $3.86M | Buy |
89,608
+61,181
| +215% | +$2.64M | 0.06% | 176 |
|
|
2021
Q2 | $1.11M | Buy |
28,427
+14,291
| +101% | +$559K | 0.03% | 231 |
|
|
2021
Q1 | $512 | Sell |
14,136
-14,447
| -51% | -$523 | 0.01% | 267 |
|
|
2020
Q4 | $1.05M | Buy |
28,583
+3,201
| +13% | +$118K | 0.04% | 171 |
|
|
2020
Q3 | $879K | Buy |
25,382
+6,354
| +33% | +$220K | 0.04% | 174 |
|
|
2020
Q2 | $590K | Buy |
19,028
+10,526
| +124% | +$326K | 0.04% | 202 |
|
|
2020
Q1 | $263K | Sell |
8,502
-267
| -3% | -$8.26K | 0.02% | 307 |
|
|
2019
Q4 | $326K | Hold |
8,769
| – | – | 0.02% | 309 |
|
|
2019
Q3 | $299K | Sell |
8,769
-708
| -7% | -$24.1K | 0.02% | 338 |
|
|
2019
Q2 | $390K | Buy |
9,477
+1,103
| +13% | +$45.4K | 0.03% | 272 |
|
|
2019
Q1 | $336K | Sell |
8,374
-12,685
| -60% | -$509K | 0.02% | 301 |
|
|
2018
Q4 | $872K | Sell |
21,059
-223
| -1% | -$9.23K | 0.05% | 161 |
|
|
2018
Q3 | $887K | Sell |
21,282
-5,543
| -21% | -$231K | 0.04% | 221 |
|
|
2018
Q2 | $937K | Buy |
+26,825
| New | +$937K | 0.04% | 218 |
|